Status
Conditions
Treatments
About
The purpose of this study is to learn about possible changes in thinking (cognitive) abilities, such as memory skills, and in brain anatomy and function, in adults with multiple myeloma who are treated with high-dose chemotherapy followed by ASCT.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnosed with multiple myeloma and in complete, partial or very good partial remission at enrollment as per standard International Myeloma Working Group Criteria
Scheduled to have high-dose chemotherapy and ASCT
Age 60 - 75 years at study entry
In the judgment of the consenting professional, fluent and able to communicate well enough in English to complete the study assessments and provide informed consent.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
18 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal